# Rocket Pharmaceuticals, Inc.: Form 8-K, filed Nov 18, 2024

- Company: [Rocket Pharmaceuticals, Inc.](/companies/rckt.md) (CIK 1281895)
- Form: 8-K
- Filed: 2024-11-18
- Accepted by EDGAR: Nov 18, 2024, 16:15 ET
- Period: 2024-11-18
- Accession: 0001140361-24-047166
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1281895/000114036124047166/ef20038805_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1281895/000114036124047166/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1281895/000114036124047166/ef20038805_8k.htm

Filed Nov 18, 2024.
Source: SEC EDGAR, the filing index for accession 0001140361-24-047166. Last ingested by Listed: Oct 30, 2026, 13:58 ET. No prices; not investment advice.